Rankings
▼
Calendar
XOMAP Q1 2022 Earnings — XOMA Corporation Revenue & Financial Results | Market Cap Arena
XOMAP
XOMA Corporation
$311M
Q1 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$3M
+728.5% YoY
Gross Profit
$3M
98.2% margin
Operating Income
-$2M
-66.5% margin
Net Income
-$2M
-73.4% margin
EPS (Diluted)
$-0.22
QoQ Revenue Growth
-91.4%
Cash Flow
Operating Cash Flow
-$1M
Free Cash Flow
-$1M
Stock-Based Comp.
$978,000
Balance Sheet
Total Assets
$159M
Total Liabilities
$19M
Stockholders' Equity
$140M
Cash & Equivalents
$88M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$3M
$375,000
+728.5%
Gross Profit
$3M
$314,000
+871.7%
Operating Income
-$2M
-$6M
+67.9%
Net Income
-$2M
-$7M
+69.1%
← FY 2022
All Quarters
Q2 2022 →